Literature DB >> 20832197

Factors associated with attendance in 12-step groups (Alcoholics Anonymous/Narcotics Anonymous) among adults with alcohol problems living with HIV/AIDS.

John Orwat1, Jeffrey H Samet, Christopher P Tompkins, Debbie M Cheng, Michael P Dentato, Richard Saitz.   

Abstract

BACKGROUND: Despite the value of 12-step meetings, few studies have examined factors associated with attendance among those living with HIV/AIDS, such as the impact of HIV disease severity and demographics.
OBJECTIVE: This study examines predisposing characteristics, enabling resources and need on attendance at Alcoholic Anonymous (AA) and Narcotics Anonymous (NA) meetings among those living with HIV/AIDS and alcohol problems.
METHODS: Secondary analysis of prospective data from the HIV-Longitudinal Interrelationships of Viruses and Ethanol study, a cohort of 400 adults living with HIV/AIDS and alcohol problems. Factors associated with AA/NA attendance were identified using the Anderson model for vulnerable populations. Generalized estimating equation logistic regression models were fit to identify factors associated with self-reported AA/NA attendance.
RESULTS: At study entry, subjects were 75% male, 12% met diagnostic criteria for alcohol dependence, 43% had drug dependence and 56% reported attending one or more AA/NA meetings (past 6 months). In the adjusted model, female gender negatively associated with attendance, as were social support systems that use alcohol and/or drugs, while presence of HCV antibody, drug dependence diagnosis, and homelessness associated with higher odds of attendance.
CONCLUSIONS: Non-substance abuse related barriers to AA/NA group attendance exist for those living with HIV/AIDS, including females and social support systems that use alcohol and/or drugs. Positive associations of homelessness, HCV infection and current drug dependence were identified. These findings provide implications for policy makers and treatment professionals who wish to encourage attendance at 12-step meetings for those living with HIV/AIDS and alcohol or other substance use problems.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20832197      PMCID: PMC3603575          DOI: 10.1016/j.drugalcdep.2010.07.021

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  53 in total

1.  Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance.

Authors:  Constance Weisner; Helen Matzger; Tammy Tam; Laura Schmidt
Journal:  J Stud Alcohol       Date:  2002-11

Review 2.  The validity of self-reports of alcohol consumption: state of the science and challenges for research.

Authors:  Frances K Del Boca; Jack Darkes
Journal:  Addiction       Date:  2003-12       Impact factor: 6.526

3.  Participation in treatment and Alcoholics Anonymous: a 16-year follow-up of initially untreated individuals.

Authors:  Rudolf H Moos; Bernice S Moos
Journal:  J Clin Psychol       Date:  2006-06

4.  Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use.

Authors:  Anita Palepu; Mark Tyndall; Benita Yip; Michael V O'Shaughnessy; Robert S Hogg; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-15       Impact factor: 3.731

5.  The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study.

Authors:  Frank H Galvan; Eric G Bing; John A Fleishman; Andrew S London; Raul Caetano; M Audrey Burnam; Doug Longshore; Sally C Morton; Maria Orlando; Martin Shapiro
Journal:  J Stud Alcohol       Date:  2002-03

6.  Clinical importance of HIV and depressive symptoms among veterans with HIV infection.

Authors:  Amy M Kilbourne; Amy C Justice; Bruce L Rollman; Kathleen A McGinnis; Linda Rabeneck; Sharon Weissman; Susan Smola; Richard Schultz; Jeff Whittle; Maria Rodriguez-Barradas
Journal:  J Gen Intern Med       Date:  2002-07       Impact factor: 5.128

7.  Reliable self-report of health service use by individuals with serious mental illness.

Authors:  Richard W Goldberg; Diana C Seybolt; Anthony Lehman
Journal:  Psychiatr Serv       Date:  2002-07       Impact factor: 3.084

8.  Psychiatric comorbidity and the prevalence of HIV infection in a sample of patients in treatment for substance abuse.

Authors:  David J Dausey; Rani A Desai
Journal:  J Nerv Ment Dis       Date:  2003-01       Impact factor: 2.254

9.  Differences in HIV disease progression by injecting drug use in HIV-infected persons in care.

Authors:  Richard D Moore; Jeanne C Keruly; Richard E Chaisson
Journal:  J Acquir Immune Defic Syndr       Date:  2004-01-01       Impact factor: 3.731

10.  Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people.

Authors:  Frank H Galvan; M Audrey Burnam; Eric G Bing
Journal:  J Psychoactive Drugs       Date:  2003-05
View more
  5 in total

1.  Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems.

Authors:  John Orwat; Richard Saitz; Christopher P Tompkins; Debbie M Cheng; Michael P Dentato; Jeffrey H Samet
Journal:  J Subst Abuse Treat       Date:  2011-06-22

2.  Do 12-step meeting attendance trajectories over 9 years predict abstinence?

Authors:  Jane Witbrodt; Jennifer Mertens; Lee Ann Kaskutas; Jason Bond; Felicia Chi; Constance Weisner
Journal:  J Subst Abuse Treat       Date:  2011-12-27

3.  Factors associated with first utilization of different types of care for alcohol problems.

Authors:  Deborah A Dawson; Risë B Goldstein; Bridget F Grant
Journal:  J Stud Alcohol Drugs       Date:  2012-07       Impact factor: 2.582

4.  Willingness to Receive Treatment for Hepatitis C among Injecting Drug Users on Methadone Program: Implications for Education and Treatment.

Authors:  Zahra Alam-Mehrjerdi; Afsaneh Moradi; Fenglian Xu; Mehran Zarghami; Javad Salehi-Fadardi; Kate Dolan
Journal:  Addict Health       Date:  2016-04

5.  The exploration of factors related to treatment retention in Narcotics Anonymous members: a qualitative study.

Authors:  Rostam Jalali; Asie Moradi; Fateme Dehghan; Samira Merzai; Mostafa Alikhani
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.